Literature DB >> 19111949

A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease.

Lauren B Gerson1, Ronnie Fass.   

Abstract

BACKGROUND & AIMS: More than half of patients with chronic gastroesophageal reflux (GERD) report nocturnal symptoms. We performed systematic literature review to define nocturnal heartburn and to determine potential causality between nocturnal reflux and extraesophageal manifestations.
METHODS: We performed a search of literature published from 1974-2007. Each study was examined by 2 reviewers and rated on the basis of study type and outcome.
RESULTS: Screening of 445 trials identified 59 (13%) studies relevant for analysis. Twenty-two (5%) of the trials described potential changes in sleep parameters resulting from treatment of heartburn. In most studies, nocturnal reflux was defined as heartburn symptoms that impacted sleep quality and duration. On the basis of 5 large population studies, the mean +/- standard deviation prevalence of nocturnal heartburn was 54% +/- 22%. Consequences of nocturnal reflux included poor sleep quality, daytime fatigue, difficulty initiating sleep or arousals from sleep, and impaired work productivity. The strength of the association between the occurrence of nocturnal reflux and late evening meals was flawed as a result of the confounding effect of the evening meal content. There was no evidence supporting causality between nocturnal heartburn and asthma or obstructive sleep apnea. Subjective, but not objective, measures of sleep improved with antireflux therapy. Head of bed elevation, proton pump inhibitor therapy, H(2)-receptor antagonists, and Nissen fundoplication alleviated nocturnal heartburn and associated sleep disturbances.
CONCLUSIONS: Nocturnal GERD is common and is associated with adverse sleep parameters. It can be effectively managed with medical and surgical therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19111949     DOI: 10.1016/j.cgh.2008.11.021

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  23 in total

1.  Night-time symptoms and their impact on sleep in patients with gastroesophageal reflux disease who have a partial response to proton pump inhibitors: a qualitative patient interview study.

Authors:  Anna Rydén; Mona Martin; Katarina Halling; Anna Niklasson
Journal:  Patient       Date:  2013       Impact factor: 3.883

Review 2.  Gastroesophageal reflux disease and sleep disturbances.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa; Ronnie Fass
Journal:  J Gastroenterol       Date:  2012-05-17       Impact factor: 7.527

Review 3.  Advancements in the analysis of esophageal pH monitoring in GERD.

Authors:  Tiberiu Hershcovici; Anita Gasiorowska; Ronnie Fass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

4.  Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities?

Authors:  R S Choung; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2011-12-12       Impact factor: 3.598

5.  Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications.

Authors:  Hye-Kyung Jung; Rok Seon Choung; Nicholas J Talley
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 6.  [Bronchopulmonary manifestations of gastroesophageal reflux disease].

Authors:  M V Malfertheiner; A Kandulski; P Malfertheiner; J Schreiber
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

7.  Hiatal hernia predisposes to nocturnal gastro-oesophageal reflux.

Authors:  Georgios Karamanolis; Dimitrios Polymeros; Konstantinos Triantafyllou; Adam Adamopoulos; Charalampos Barbatzas; Irini Vafiadis; Spiros D Ladas
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

8.  An association between unrecognized gastroesophageal reflux disease and excessive daytime sleepiness in Taiwanese subjects suspected to have liver disease: a pilot study.

Authors:  Jing-Hong Hu; Shih-Wei Lin; Yung-Yu Hsieh; Ning-Hung Chen
Journal:  BMC Gastroenterol       Date:  2011-05-18       Impact factor: 3.067

9.  Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.

Authors:  Robert C Heading; Hubert Mönnikes; Anne Tholen; Holger Schmitt
Journal:  BMC Gastroenterol       Date:  2011-05-11       Impact factor: 3.067

10.  Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication.

Authors:  Luigi Bonavina; Thomas Horbach; Sebastian F Schoppmann; Janet DeMarchi
Journal:  Surg Endosc       Date:  2020-07-16       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.